
Granitag 3mg Injection
Marketer
Innovative Pharmaceuticals
Salt Composition
Granisetron (3mg)
Overview Granitag 3mg Injection
Onvex 3mg Injection, an antiemetic medication, effectively manages nausea and vomiting stemming from surgery, chemotherapy, or radiation therapy. However, it doesn't address other cancer treatment side effects. Administered by a healthcare provider, its use should strictly follow medical instructions. Continued injections are crucial until your physician deems it safe to discontinue. Subsequent treatment might involve oral medication. Common side effects, such as injection site discomfort, headache, bowel irregularities (constipation or diarrhea), and fatigue, typically subside upon treatment cessation. Persistent or bothersome symptoms warrant discussion with your doctor, who can offer mitigation strategies. Prior to treatment, disclose any heart, liver, or gastrointestinal obstructions to your physician. Additionally, inform them of all other medications, especially those for epilepsy, cardiac issues, cancer, or depression, as interactions are possible. Pregnant or breastfeeding individuals should consult their healthcare team for guidance.
Uses of Granitag 3mg Injection
Chemotherapy-induced emesis
Major Benefits of Granitag 3mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Granitag 3mg Injection:
- Injection site pain
- Constipation
- Diarrhea
- Headache
- Weakness
- Insomnia (difficulty in sleeping)
How to use Granitag 3mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Granitag 3mg Injection works:
Granitag 3mg Injection, an antiemetic, counteracts nausea and vomiting. This effect is achieved by inhibiting serotonin, a neurotransmitter in the brain that can trigger these symptoms following surgery or chemotherapy.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Granitag 3mg Injection may pose safety risks; physician consultation is advised.
PregnancySAFE IF PRESCRIBED
Granitag 3mg Injection is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nonetheless, clinical data from human subjects remain scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Granitag 3mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Granitag 3mg Injection.
KidneySAFE IF PRESCRIBED
The use of Granitag 3mg Injection in individuals with kidney impairment appears to pose minimal risk. Preliminary evidence indicates dose modification may be unnecessary; however, physician consultation is advised.
LiverSAFE IF PRESCRIBED
Granitag 3mg Injection appears safe for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary. However, physician consultation is recommended.
What if you forget to take Granitag 3mg Injection :
Should you forget a Granitag 3mg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Granitag 3mg Injection
| Label | Value |
|---|---|
| Chemical Category | Indazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavioral Class | 5-HT3 receptor blockers |
